The makers of the popular weight loss drug Wegovy say new data, from one of their longest medical trials to date, shows the drug has sustained benefits.
Novo Nordisk says patients taking the drug maintained an average 10 per cent weight loss after four years on the treatment.
After years of persistent shortages, the drug finally became available to Canadians as of last week, despite being greenlit since 2021.
Global health reporter Katherine Ward has more on the results of the trial.
For more info, please go to https://globalnews.ca/news/10476494/wegovy-drug-canada-weight-loss-drug/
Subscribe to Global News Channel HERE: http://bit.ly/20fcXDc
Like Global News on Facebook HERE: http://bit.ly/255GMJQ
Follow Global News on X HERE: http://bit.ly/1Toz8mt
Follow Global News on Instagram HERE: https://bit.ly/2QZaZIB
#GlobalNews #wegovy #wegovyweightloss
Novo Nordisk says patients taking the drug maintained an average 10 per cent weight loss after four years on the treatment.
After years of persistent shortages, the drug finally became available to Canadians as of last week, despite being greenlit since 2021.
Global health reporter Katherine Ward has more on the results of the trial.
For more info, please go to https://globalnews.ca/news/10476494/wegovy-drug-canada-weight-loss-drug/
Subscribe to Global News Channel HERE: http://bit.ly/20fcXDc
Like Global News on Facebook HERE: http://bit.ly/255GMJQ
Follow Global News on X HERE: http://bit.ly/1Toz8mt
Follow Global News on Instagram HERE: https://bit.ly/2QZaZIB
#GlobalNews #wegovy #wegovyweightloss
- Category
- U.S. & Canada
- Tags
- global news, Wegovy, Wegovy weight loss
Sign in or sign up to post comments.
Be the first to comment